| 1 |
Which of the following best describes the concept of "beat perception" as it relates to the auditory capabilities of newborn infants?
|
The extraction of a consistent rhythm from a sequence of sounds. |
|
Beat perception is the way we find rhythm in the sound.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
According to the research, what experimental method is used to differentiate beat perception from statistical learning in newborns?
|
Monitoring brain activity using EEG during auditory stimulation. |
|
EEG use to measure electrical activity in the brain that come from rhythmic sequences.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does the mismatch response (MMR) in EEG studies indicate about newborns' auditory processing?
|
Sensitivity to regularity violations in sound sequences. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What does the term "statistical learning" refer to in the context of auditory processing in newborns?
|
Extraction of regularities from the order of sounds without explicit feedback. |
|
Refer to statistical data newborns Can recognize word from speech that others people say to them they listen to word and their brain will learn and connect automatically without anyone teaching.
|
Statistical learning is fundamental method that help we to understand and adapt in with environment automatically for instance that baby learning to understand the word by recognizing the sound of word that they hear.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which condition in the EEG study did NOT result in a differentiation between beat and offbeat responses in newborns?
|
Jittered condition. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Which neural mechanism is thought to underlie the synchronization of movement to a beat?
|
Neural entrainment. |
|
Brain ability to synchronization of movement to an external beat (environment)
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How does beat perception in newborns relate to their later musical abilities?
|
It is fundamental for developing rhythmic coordination and timing. |
|
It is fundamental stage for later rhythms ability
|
Neuroscience of music
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is the primary purpose of using EEG in studies of auditory processing in newborns?
|
To record brain responses to sounds. |
|
EEG is to measure electrical activity of brain that responds to sound .
|
The question ask about eeg which is method that measure electrical activity so it not relate to heart visual or sleep and question said auditory means about sound so it not motor skill so it have only one answer.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What does an isochronous condition in an auditory study typically involve?
|
A consistent temporal interval between sounds. |
|
Isochronous is random intervals between sound use to study hearing for brain to predict rhythm
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Which auditory feature is NOT directly studied in the newborn auditory processing research?
|
Language comprehension. |
|
Beat Perception , Statistical Learning , Rhythmic Entrainment, Melody Recognition is directly auditory feature that has been studied.
|
Language comprehension is not directly study because it to early to study development of brains during brain improper growth.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What term is used to describe the appearance of scientific credibility used in the marketing of unproven cell-based therapies?
|
Tokens of scientific legitimacy |
|
“Tokens of Scientific Legitimacy” means signs or symbols of scientific credibility. In the case of cell-based therapies that have not received regulatory approval or lack evidence, they are often advertise with “tokens.”
|
“Tokens of Scientific Legitimacy” means “signs or symbols of scientific credibility.”
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
According to the article, which of the following is NOT a recognized reporting mechanism for adverse effects from cell and gene therapies?
|
Consumer Protection Agencies |
|
These organizations play a role in protecting the general consumer, but are not clinical or medical mechanisms designed to monitor the safety of drugs
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What ethical consideration is primarily challenged by direct-to-consumer marketing of unproven cell and gene therapies?
|
Informed consent processes |
|
Direct-to-Consumer (DTC) Marketing, or the advertising and offering of cell and gene therapies directly to consumers, a procedure for which there is insufficient scientific evidence, poses a significant ethical challenge to the principle of “informed consent.”
|
Every person has the right to the best possible treatment, safety and truth.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What key feature differentiates proven CGT products from unproven ones according to regulatory standards?
|
Pre-marketing authorization by regulatory bodies |
|
“Pre-Marketing Authorization” or the fact that a product has been approved before it is marketed by a regulatory agency is an important characteristic used to distinguish between “proven” and “unproven” CGT
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which of the following is a risk associated with unproven CGT products highlighted in the article?
|
Potential for serious health risks |
|
Not properly tested for human safety. There is a risk of variety harm disease .
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Which of the following is NOT a typical characteristic of unproven CGT products as discussed in the article?
|
Approval by major regulatory agencies |
|
Unproven CGT products, according to the article, lack appropriate scientific and medical standards and are not approved by major regulatory agencies.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
How do regulatory bodies like the FDA and EMA ensure the safety of CGT products?
|
By requiring rigorous pre-marketing clinical trials |
|
For example, the FDA and EMA have a primary responsibility to protect patient safety and ensure that Cell and Gene Therapy (CGT) products are safe and effective before they enter the market.
|
Rigorous clinical trials are required before it is approved for sale or use in patients.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the primary goal of the ISCT's position on cell and gene therapies as mentioned in the article?
|
To support evidence-based products and oppose unproven ones |
|
The main goal of ISCT is to promote safety standards.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What is a potential consequence for patients using unproven CGT products?
|
Risk of serious adverse effects |
|
When patients use CGT or Cell and gene therapy products is very risk because it is unproven things so if it in indirectly ways that it need to be. It may cause a dramatic effect.
|
Every therapy that will use to patients or human need to be experimented the effects and side effects and approved before lets patients use.
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What role does the ISCT play in the context of cell and gene therapies?
|
It opposes the premature commercialization of unproven therapies. |
|
ISCT this one work to encourage clinic that use cell or gene therapy to have response to patients not use any unproven treatments .
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|